title: Comparative effectiveness research in urologic cancers.
abstract: Controversies abound in urologic cancers. While some work in comparative effectiveness research has been performed, most controversies remain unresolved. In this chapter, we examine the three most common urologic malignancies: Prostate cancer, kidney cancer, and bladder cancer. We will review progress made in comparative effectiveness research for each cancer and outline important topics where future research is needed.
authors: Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA, stropes@wudosis.wustl.edu.
authors: Seth A
authors: SA
authors: Strope
mesh_terms: D057186:Comparative Effectiveness Research / Q000379:methods*; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D008297:Male; D009364:Neoplasm Recurrence, Local; D009392:Nephrectomy / Q000379:methods; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D014571:Urologic Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*